European life sciences venture firm Forbion on Tuesday said it has raised 2 billion euros, or more than $2.2 billion, for two of its newest investment funds. Forbion Growth Opportunities III pulled in ...
NAARDEN, The Netherlands, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Forbion, a leading global life sciences venture capital firm with deep expertise in Europe, today announces that it has raised over €2 ...
- Brings extensive international investment and board experience in life sciences companies of all sizes including company creations, private venture deals and IPOs - Naarden, The ...
€750 million raised in the final close of the Forbion Ventures Fund VI €600 million raised in the final close of the Forbion Growth Opportunities Fund II Brings the total of funds under management at ...
Forbion, a Dutch life sciences venture capital firm, hired former Dyne Therapeutics CEO Josh Brumm as a general partner Thursday morning. Brumm, who previously helmed the estimated $3.5 billion ...
NAARDEN, The Netherlands--(BUSINESS WIRE)--Forbion, one of the leading European life science venture capital firms, today announced that it led the $19 million Series B financing of Escalier ...
NAARDEN, The Netherlands, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Forbion, a leading life sciences venture capital firm with deep roots in Europe, today announces that GSK (NYSE: GSK) has entered into a ...
NAARDEN, The Netherlands, and MUNICH--(BUSINESS WIRE)--Forbion, a leading European life science venture capital firm, has today announced the final close of its new flagship fund, Forbion IV. The ...
Forbion has raised a €460 million ($558 million) early-stage venture capital fund. The fund hit its hard cap weeks after opening, adding further evidence of the willingness of investors to back ...
“If a company isn’t IPO-ready, it better be M&A-ready,” says Nanna Luneborg of Forbion. She and co-founder Sander Slootweg sit down with Bloomberg Intelligence analyst Sam Fazeli to explain Forbion’s ...
Forbion's largest fundraising to date, with Forbion's Growth Opportunities Fund III raising €1.2 billion and Forbion Ventures Fund VII raising €890 million Assets under management now at €5 billion ...